Drupal.behaviors.print = function(context) {window.print();window.close();}>
Vermillion Gets Nasdaq Warning
January 07, 2013
Vermillion Gets Nasdaq Warning
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Vermillion Sends Quest Notice of Default Alleging Breach of Strategic Alliance Agreement
May 24, 2013 / ProteoMonitor
Vermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization Strategy
May 17, 2013 / ProteoMonitor
GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor
Vermillion Inks CRADA with Army to Evaluate OVA1
April 17, 2013 / GenomeWeb Daily News
Vermillion Posts 11 Percent Rise in 2012 Revenues, 8 Percent Uptick in OVA1 Sales
February 22, 2013 / ProteoMonitor